These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23781136)

  • 1. Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis.
    Ding J; Chen Z; Feng K
    Int J Med Sci; 2013; 10(7):903-7. PubMed ID: 23781136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
    Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
    Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up.
    Long W; Li LJ; Huang GZ; Zhang XM; Zhang YC; Tang JG; Zhang Y; Lu G
    Crit Care; 2014 Sep; 18(5):471. PubMed ID: 25189222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial.
    Wang JX; Zhang SM; Li XH; Zhang Y; Xu ZY; Cao B
    Int J Infect Dis; 2016 Jul; 48():40-5. PubMed ID: 27155210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
    Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
    BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Procalcitonin-guided algorithms of antibiotic therapy in community-acquired lower respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials].
    Zhang L; Huang J; Xu T; Lin Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Apr; 35(4):275-82. PubMed ID: 22781200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.
    Schuetz P; Briel M; Christ-Crain M; Stolz D; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Kristoffersen KB; Wei L; Burkhardt O; Welte T; Schroeder S; Nobre V; Tamm M; Bhatnagar N; Bucher HC; Mueller B
    Clin Infect Dis; 2012 Sep; 55(5):651-62. PubMed ID: 22573847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.
    Maravić-Stojković V; Lausević-Vuk L; Jović M; Ranković A; Borzanović M; Marinković J
    Srp Arh Celok Lek; 2011; 139(11-12):736-42. PubMed ID: 22338468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
    Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
    BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
    Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
    PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
    Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
    Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey.
    Schuetz P; Batschwaroff M; Dusemund F; Albrich W; Bürgi U; Maurer M; Brutsche M; Huber AR; Müller B
    Eur J Clin Microbiol Infect Dis; 2010 Mar; 29(3):269-77. PubMed ID: 20039090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
    Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
    Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis.
    Soni NJ; Samson DJ; Galaydick JL; Vats V; Huang ES; Aronson N; Pitrak DL
    J Hosp Med; 2013 Sep; 8(9):530-40. PubMed ID: 23955852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial.
    Qu R; Ji Y; Ling Y; Ye CY; Yang SM; Liu YY; Yang RY; Luo YF; Guo Z
    Saudi Med J; 2012 Apr; 33(4):382-7. PubMed ID: 22485232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.